Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Sponsored Link:
What No One Says About This 'Recession-Proof' Sector
By Rob Fannon, editor, Phase 1 Investor
October 24, 2008

Right now, you can't pass a newsstand without hitting an article touting the world's best "recession-proof" stocks.

These so-called defensive industries include groceries, cigarettes, and drugs. Supposedly, consumers will continue to spend on these items no matter the state of the economy. They may skip Cancun getaways and Coach handbags, but they won't cut insulin or heart meds. Maybe so...

But here's something you probably aren't hearing about: Patients will sacrifice a pricey brand-name drug for a cheap knock-off...

In fact, patients are already cutting back on drugs like Lipitor – Pfizer's cholesterol medication and the world's top-selling drug. They're switching to generic drugs that cost 30% as much.

For Big Pharma, this dose of bad news couldn't have come at a worse time. In 2009, the industry will face generic competition on products that currently bring in $10 billion a year.

The combination of looming patent expirations, lagging drug sales, and crummy market conditions has crushed Big Pharma stock prices. On average, the big drugmakers are down 25% on the year. Now they're yielding as much as 7.5%.

But as I warned you before, don't be tempted by Big Pharma's high yields. A protracted recession will dampen sales of the industry's top-selling products right up until these big brand-name drugs lose patent in 2010 and 2011. Big Pharma shares could fall another 20% from here. That would wipe out several years of dividends.

So if you're looking for recession-proof stocks, drugs are the right idea. But Big Pharma's not going to take good care of your cash. Instead, you should turn to major players in the generics industry. Teva Pharmaceuticals (TEVA), Mylan (MYL), and Watson Pharmaceuticals (WPI) are the biggest names.

Take a look at this one-year chart that compares Teva to my favorite whipping-boy, Pfizer (in blue):


Teva Pharmaceutical Industries

Teva handily outperformed Pfizer as the market fell apart. Sure, Teva's down about 9% on the year. But compared to the S&P's 40% beating, that's not too shabby.

Pfizer's $3 Billion Mistake

Get Rich With Drugs

Few businesses look better than a company selling cheap drugs to an aging population during tough economic times. So double-check your portfolio. If you bought Pfizer or Merck hoping to wait out the recession, you'd be better off replacing it with a name like Teva.

Good investing,

Rob

China Jumpstarts Economy
China is stepping up its efforts to boost its slowing economy by unveiling the first steps in a potentially large fiscal stimulus programme.

After weeks of debate, the government this week started to detail aggressive policy steps following Monday’s announcement that third-quarter growth slowed to 9 per cent, the lowest level in five years and well below many forecasts. FT ($) Read on...

Shipping Rates Tumble on Slowing Global Demand
Dry bulk shippers are going the way of the global economy: under water. Among the shippers, DryShips and Excel Maritime Carriers have been hit particularly hard because of their large debtloads and significant spot market exposure.

For the 13th straight day, the Baltic Dry Index, which measures dry bulk shipping rates on 40 routes across the world, tumbled Wednesday, falling 71 points to 1,221. Read on...


Greenback soars against the loonie... up 26% in three months.
Big three casinos crash... MGM Grand, Wynn Resorts, and Las Vegas Sands drop double digits to new lows.
Foreclosures up, construction down... homebuilders D.R. Horton, Lennar, Beazer, and Hovnanian hit new lows.
Earnings today... Alexander & Baldwin, Exelon, Gannett, T. Rowe Price.
Last Change 52-Wk
S&P 500

896.78

-6.10%

-40.99%

Oil (USO)

54.93

-6.53%

-16.56%

Gold (GLD)

71.71

-5.68%

-4.68%

Silver (SLV)

9.45

-5.31%

-29.80%

U.S. Dollar

85.82

+0.49%

+10.72%

Euro
1.28
-0.47%
-10.35%
VIX

69.65

+31.14%

+241.25%

HUI

168.36

-16.32%

-58.44%

10-Year Yield

3.62%

-0.08

-0.65

Advertisement

Company Sym Industry

Sears Holdings

SHLD

retail

Janus

JNS

asset mgmt

Palm

PALM

technology

Alcoa

AA

aluminum

Hovnanian

HOV

homebuilder

D.R. Horton

DHI

homebuilder

CS Canadian Dollar

FXC

ETF

Bassett Furniture

BSET

furniture

J.C. Penney

JCP

dept store

Leucadia

LUK

holding company

ABB

ABB

electrical equip

CS Euro

FXE

ETF

Dillard's

DDS

dept store

Manitowoc

MTW

heavy machinery

AXA

AXA

insurance

CS British Pound

FXB

ETF

U.S. Natural Gas

UNG

ETF

Las Vegas Sands

LVS

casinos

Beazer Homes

BZH

homebuilder

Foster Wheeler

FWLT

construction

Men's Wearhouse

MW

clothing

Alcon

ACL

medical equip

McDermott

MDR

construction

US Steel

X

steel

CB Richard Ellis

CBG

real estate

Hertz Global

HTZ

auto rental

Brunswick

BC

boats

Western Union

WU

wire transfers

MGM Mirage

MGM

casinos

Apartment Invest

AIV

apartment REIT

Sonic

SONC

restaurants

Gap

GPS

clothing

Chicago Bridge

CBI

construction

Hanesbrands

HBI

clothing

BHP Billiton

BHP

mining

Wynn Resorts

WYNN

casinos

Amazon

AMZN

online retail

Hewlett-Packard

HPQ

technology

Covance

CVD

med research

Brinker Intl

EAT

restaurants

CF Industries

CF

agriculture

Allianz

AZ

insurance

Mattel

MAT

toys

Ultra Real Estate

URE

ETF

Lennar

LEN

homebuilder

Caterpillar

CAT

heavy machinery

Jones Lang LaSalle

JLL

real estate

Beckman Coulter

BEC

medical equip

ArcelorMittal

MT

steel

SPDR Homebuilders

XHB

ETF

China Life

LFC

insurance

Deere

DE

heavy equipment

Corning

GLW

technology

Schering-Plough

SGP

Big Pharma

T. Rowe Price

TROW

asset mgmt

Belden

BDC

industrial equip

Textron

TXT

conglomerate

Siemens

SI

telecom

Under Armour

UA

athletic apparel

SL Green

SLG

commercial REIT

Liz Claiborne

LIZ

clothing

Borders

BGP

books

Skechers

SKX

shoes

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2010 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202